Renue by Science Launches Innovative Liposomal NAD+ Skincare Line, Renue Blue, Emphasizing Skin Wellness and Longevity

January 08, 2025 06:08 AM AEDT | By Cision
Follow us on Google News: https://kalkinemedia.com/resources/assets/public/images/google-news.webp

JACKSONVILLE, Fla., Jan. 8, 2025 /PRNewswire/ -- Renue by Science, a global leader in NAD+ precursor supplements, is excited to announce the official launch of its highly anticipated skincare range, Renue Blue. With a focus on skin longevity and holistic wellness, this revolutionary line features cutting-edge ingredients and advanced nanoliposome technology designed to deliver powerful regenerative benefits deep into the skin.

Renue Blue's skincare range has been developed using the latest research in skincare science. Each formulation includes NAD+ boosters known to promote skin rejuvenation. These include NMN (Nicotinamide Mononucleotide) and NR (Nicotinamide Riboside), alongside a novel antioxidant, Methylene Blue. These and other medical-grade ingredients have been scientifically validated to support cellular health and enhance skin vitality.

What sets the Renue Blue skincare line apart is its superior mode of delivery. Liposomes safely carry the active ingredients, which include an NAD+ Complex (NAD+, NMN & NR), Resveratrol, and Apocynin, past the outer skin barrier and deep into your cells. The formulation allows for these potent ingredients to reach the target site before releasing them to offer a targeted skin treatment. As a result, Renue Blue offers an innovative approach to skincare, combining the latest breakthroughs in scientific research with the pursuit of achieving the appearance of healthier, more radiant skin.

"We have seen tremendous success with NAD+ Boosters with Renue by Science over the past 7 years and felt that the market and demand for topical skincare applications of NAD+ was expanding, so creating Renue Blue has allowed us to focus research and development on skincare along with the introduction of other novel ingredients such as Methylene Blue, the hero ingredient and inspiration for the brand," said Bryan Nettles/CEO & Founder of Renue by Science. "With Renue Blue, we're not just offering skincare products; we're providing a comprehensive, research-driven solution for forward-thinking individuals who want to optimize their skincare routine while promoting overall wellness and skin longevity."

The launch coincides with the unveiling of a new website, renueblue.com, where you can explore the complete Renue Blue collection, learn about the science behind the ingredients, and discover tips for integrating the products into your skincare routine. The user-friendly site will serve as the go-to destination for those committed to looking and feeling their best.

Renue Blue is designed for anyone who values health, wellness, and longevity. As the brand enters the skincare market, it aims to empower the longevity community with research, knowledge, and tools to enhance their skin health—increasing not only their skin's resilience but also their confidence.

To learn more about Renue Blue and to shop the new collection, visit renueblue.com.

About Renue by Science

Renue By Science is committed to advancing longevity science by making the latest breakthroughs globally accessible. We specialize in developing innovative supplement formulations that enhance rejuvenation and optimize energy production, empowering individuals to not only extend their lifespan but also improve their quality of life. Our mission is to harness research-backed ingredients and integrate them into bioavailable delivery systems that enhance both health span and lifespan.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.

This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.

Two ASX Listed Stocks Giving Bullish Indications

Recent Articles

Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.